CureVac is suing BioNTech for stealing mRNA vaccine technology. After trying to create its own COVID-19 vaccine, CureVac is bringing four patent infringement claims against fellow German mRNA pioneer BioNTech.
CureVac is still vying for market share a year after its COVID-19 vaccine contender had a high-profile failure.
On Monday, the business said that it is suing fellow German mRNA pioneer BioNTech for violating its intellectual property by creating the COVID shot Comirnaty in colla...
